Bratt O. Re: Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Goteborg-2 Prostate Cancer Screening Trial. Eur Urol 2024 Aug 17:S0302-2838(24)02523-5. doi: 10.1016/j.eururo.2024.
PMID: 39153930